DEBORAH DUCHESNEAU: Open Payments
NPI 1790713501 · WHITEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$278 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $210 · 2025 $278
Food & beverage: $278
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $73 |
| Novo Nordisk Inc | 3 | $62 |
| ABBVIE INC. | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, Wegovy, LINZESS, INSPIRE, FARXIGA, IBSRELA, QULIPTA, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
